Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4)
Latest & greatest articles for chronic kidney disease
The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on chronic kidney disease or other clinical topics then use Trip today.
This page lists the very latest high quality evidence on chronic kidney disease and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.
What is Trip?
Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.
Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.
As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.
For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via email@example.com
Oral Magnesium Supplementation in ChronicKidneyDisease Stages 3 and 4: Efficacy, Safety, and Effect on Serum Calcification Propensityâ€”AÂ Prospective Randomized Double-Blinded Placebo-Controlled Clinical Trial Chronickidneydisease (CKD) is associated with high cardiovascular morbidity and mortality. Recent evidence suggests that increases in both serum and intracellular magnesium (Mg) can slow or even prevent the development of vascular calcification seen in CKD. Serum calcification
A systematic review of the effects of impaired glucose tolerance (IGT) on the incidence of chronickidneydisease (CKD) in young adults A systematic review of the effects of impaired glucose tolerance (IGT) on the incidence of chronickidneydisease (CKD) in young adults | Jadhakhan | British Journal of Diabetes User Username Password Remember me 5th Joint Meeting of ABCD & The Renal Association 24/25 February 2021 All issues 2014-present Browse Search All issues from 2014 Refine 2001-2013 (...) , Iseki C, Tokashiki K, et al. Metabolic syndrome and risk of developing chronickidneydisease in Japanese adults. Hypertens Res 2007;30:937-43. http://dx.doi.org/10.1291/hypres.30.937 Nelson RG, Pettitt DJ, Baird HR, et al. Pre-diabetic blood pressure predicts urinary albumin excretion after the onset of type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia 1993;36:998-1001. http://dx.doi.org/10.1007/BF02374490 Rashidi A, Ghanbarian A, Azizi F. Are patients who have
Traditional Thermal Therapy with Indirect Moxibustion Decreases Renal Arterial Resistive Index in Patients with ChronicKidneyDisease. To evaluate the immediate effects of traditional local thermal therapy with indirect moxibustion on renal hemodynamics in patients with chronickidneydisease (CKD) by using Doppler ultrasonography (US).Examiner-blinded crossover study.Forty-three participants with CKD (mean age ± standard deviation [SD], 44 ± 15 years; estimated glomerular filtration rate (...) , 69.5 ± 25.5 mL/min per 1.73 m(2); 20 men and 23 women).Participants received three successive treatment sessions of indirect moxibustion bilaterally at BL 23, a crucial acupuncture point, in the session. In the control session, the examiner was blinded by using smoke and aroma produced by moxibustion performed in an ashtray placed near the patient's body.The main outcome measure was resistive index (RI) in the renal segmental arteries. Blood flow parameters, including RI, were measured for six
Insulin resistance in chronickidneydisease: a systematic review Insulin resistance in chronickidneydisease: a systematic review | American Journal of Physiology-Renal Physiology Login to your account Quick Search anywhere Search all content Search Advanced Search Quick Search in Journals Search all content Search Advanced Search Archive of all online content January 1977 January 2021 January 2021 Pages F1-F144 Quick Search in Journals Search this journal Search Search this journal Issues (...) Clinica, Clinical Epidemiology and Physiopathology of RenalDiseases and Hypertension, Reggio di Calabria, Italy , and Consiglio Nazionale delle Ricerche-Istituto di Fisiologia Clinica, Clinical Epidemiology and Physiopathology of RenalDiseases and Hypertension, Reggio di Calabria, Italy Published Online: 01 Dec 2016 Share on Abstract Insulin resistance (IR) is an early metabolic alteration in chronickidneydisease (CKD) patients, being apparent when the glomerular filtration rate is still within
ChronicKidneyDisease. The definition and classification of chronickidneydisease (CKD) have evolved over time, but current international guidelines define this condition as decreased kidney function shown by glomerular filtration rate (GFR) of less than 60 mL/min per 1·73 m2, or markers of kidney damage, or both, of at least 3 months duration, regardless of the underlying cause. Diabetes and hypertension are the main causes of CKD in all high-income and middle-income countries, and also (...) is measured either via exogenous markers (eg, DTPA, iohexol), or estimated using equations. Presence of proteinuria is associated with increased risk of progression of CKD and death. Kidney biopsy samples can show definitive evidence of CKD, through common changes such as glomerular sclerosis, tubular atrophy, and interstitial fibrosis. Complications include anaemia due to reduced production of erythropoietin by the kidney; reduced red blood cell survival and iron deficiency; and mineral bone disease
Metabolically Healthy Obesity and Development of ChronicKidneyDisease 27842407 2017 12 07 2018 12 02 1539-3704 165 10 2016 11 15 Annals of internal medicine Ann. Intern. Med. Metabolically Healthy Obesity and Development of ChronicKidneyDisease. 743 10.7326/L16-0407 Kahn Henry S HS From Centers for Disease Control and Prevention, Atlanta, Georgia. Pavkov Meda E ME From Centers for Disease Control and Prevention, Atlanta, Georgia. eng CC999999 Intramural CDC HHS United States Journal Article (...) Comment United States Ann Intern Med 0372351 0003-4819 AIM IM Ann Intern Med. 2016 Mar 1;164(5):305-12 26857595 Ann Intern Med. 2016 Nov 15;165(10 ):744-745 27842405 Body Mass Index Humans Obesity Obesity, Metabolically Benign Renal Insufficiency, Chronic 2016 11 15 6 0 2016 11 15 6 0 2017 12 8 6 0 ppublish 27842407 2582915 10.7326/L16-0407 PMC5308792 NIHMS848359 Int J Obes (Lond). 2016 May;40(5):883-6 26841729 PLoS One. 2016 Jan 05;11(1):e0146057 26731527 Ann Intern Med. 2016 Mar 1;164(5):305-12
Sarcopenia, Obesity, and Mortality in US Adults With and Without ChronicKidneyDisease In pre-dialysis chronickidneydisease (CKD), the association of muscle mass with mortality is poorly defined, and no study has examined outcomes related to the co-occurrence of low muscle mass and excess adiposity (sarcopenic-obesity). Methods: We examined abnormalities of muscle and fat mass in adult participants of the National Health and Nutrition Examination Survey 1999-2004. We determined whether
Downregulation of AdipoR1 is Associated with increased Circulating Adiponectin Levels in Serbian ChronicKidneyDisease Patients Since the rise in plasma adiponectin levels in chronickidneydisease (CKD) patients has not yet been elucidated, we sought to investigate if patients on hemodialysis (HD) have altered expression of adiponectin receptors in peripheral blood mononuclear cells (PBMCs) compared to healthy subjects.This study included 31 patients with chronickidneydisease on HD and 33
Hypertension Control, Apparent Treatment Resistance, and Outcomes in the Elderly Population With ChronicKidneyDiseaseChronickidneydisease (CKD) is often associated with poor hypertension control and treatment resistance, but whether CKD modifies the effect of hypertension control on outcomes is unknown.We studied 10-year mortality and cardiovascular events according to hypertension control status and CKD (glomerular filtration rate <60 ml/min/1.73m2) in 4262 community-dwelling individuals
Tackling the Fallout From ChronicKidneyDisease of Unknown Etiology: Why We Need to Focus on Providing Peritoneal Dialysis in Rural, Low-Resource Settings 29142936 2018 11 13 2468-0249 2 1 2017 Jan Kidney international reports Kidney Int Rep Tackling the Fallout From ChronicKidneyDisease of Unknown Etiology: Why We Need to Focus on Providing Peritoneal Dialysis in Rural, Low-Resource Settings. 1-4 10.1016/j.ekir.2016.10.004 Nanayakkara Nishanthe N Department of Medicine, Teaching Hospital (...) , Kandy, Sri Lanka. Wazil A W M AWM Department of Medicine, Teaching Hospital, Kandy, Sri Lanka. Gunerathne Lishanthe L Department of Medicine, Renal Care and Research Unit, Girandurukotte, Sri Lanka. Dickowita Sewmini S Department of Medicine, Teaching Hospital, Kandy, Sri Lanka. Rope Robert R Department of Medicine, Division of Nephrology, Stanford University School of Medicine, Palo Alto, California, USA. Ratnayake Charaka C Department of Medicine, Teaching Hospital, Kandy, Sri Lanka. Saxena Anjali
Timely Referral to Outpatient Nephrology Care Slows Progression and Reduces Treatment Costs of ChronicKidneyDiseases We present a new approach to evaluate the importance of ambulatory nephrology care in patients with chronickidneydisease (CKD).An anonymized health claims database of German insurance companies was searched in a retrospective analysis for patients with CKD using the codes of the International Classification of Diseases, 10th German modification. A total of 105,219 patients (...) with CKD were identified. Patients were assigned to the group "timely referral," when nephrology care was present in the starting year 2009, or initiated during the following 3 years in CKD1-4. Using frequency matching for age and gender, 21,024 of the late referral group were matched with the equal number of patients in the timely referral group. Hospital admission rates, total treatment costs, and kidney function (change in CKD stages, start of dialysis, mortality) were documented each year during
Interventions for chronickidneydisease in people with sickle cell disease. This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effectiveness of any intervention in preventing or reducing kidney complications or CKD in people with SCD (including red blood cell transfusions, hydroxyurea and ACEI (either alone or in combination with each other)).
The Green Tea Polyphenol(â€”)-epigallocatechin-3-gallate and its beneficial roles in chronickidneydiseaseChronickidneydisease (CKD), a condition that affects around 10% of the population, has become a significant public health concern. Current therapeutic strategies to slow down the progression of CKD remain limited. Thus, it is urgent to develop new strategies to manage the patients with CKD. Work within the past decade has improved our understanding of the mechanisms contributing to CKD (...) . In particular, oxidative stress as well as inflammation appears to play a pivotal role in CKD progression. ()-Epigallocatechin-3-gallate (EGCG), the major catechin of green tea extract, is known as a powerful antioxidant and reactive oxygen species scavenger. Various studies have shown EGCG has a potential role in chronickidneydisease models. It is suggested that EGCG modulates cellular and molecular mechanisms via inflammation-related NF-кB and Nrf2 signaling pathway, as well as apoptosis-related ER
Depression in ChronicKidneyDisease and End-Stage RenalDisease: Similarities and Differences in Diagnosis, Epidemiology, andÂ Management Depression is highly prevalent and is associated with poor quality of life and increased mortality among adults with chronickidneydisease (CKD), including those with end-stage renaldisease (ESRD). However, there are several important differences in the diagnosis, epidemiology, and management of depression between patients with non-dialysis-dependent CKD
Evaluation of Renal Blood Flow in ChronicKidneyDisease Using Arterial Spin Labeling Perfusion Magnetic Resonance Imaging Chronickidneydisease (CKD) is known to be associated with reduced renal blood flow. However, data to-date in humans is limited.In this study, non-invasive arterial spin labeling (ASL) MRI data was acquired in 33 patients with diabetes and stage-3 CKD, and 30 healthy controls.A significantly lower renal blood flow both in cortex (108.4±36.4 vs. 207.3±41.8; p<0.001, d=2.52 (...) to separate healthy and CKD was estimated to be Cor_BF=142.9 and Med_BF=24.1.These results support the use of ASL in the evaluation of renal blood flow in patients with moderate level of CKD. Whether these measurements can identify subjects at risk of progressive CKD requires further longitudinal follow-up.
Efficacy of Folic Acid Therapy on the Progression of ChronicKidneyDisease: The Renal Substudy of the China Stroke Primary Prevention Trial The efficacy of folic acid therapy on renal outcomes has not been previously investigated in populations without folic acid fortification.To test whether treatment with enalapril and folic acid is more effective in slowing renal function decline than enalapril alone across a spectrum of renal function at baseline from normal to moderate chronickidney (...) was the progression of CKD, defined as a decrease in eGFR of 30% or more and to a level of less than 60 mL/min/1.73 m2 if the baseline eGFR was 60 mL/min/1.73 m2 or more, or a decrease in eGFR of 50% or more if the baseline eGFR was less than 60 mL/min/1.73 m2; or end-stage renaldisease. Secondary outcomes included a composite of the primary outcome and all-cause death, rapid decline in renal function, and rate of eGFR decline.Overall, 15 104 Chinese adults with a mean (range) age of 60 (45-75) years were
Iron (III) isomaltoside 1000 (Diafer) - iron deficiency in adults with chronickidneydisease (CKD) on dialysis 1 Published 13 February 2017 Re-submission iron III isomaltoside 1000 (contains 50mg iron per mL) (Diafer ® ), solution for injection SMC No. (1177/16) Pharmacosmos UK Limited 13 January 2017 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product and advises NHS Boards and Area Drug and Therapeutic Committees (ADTCs) on its use in Scotland (...) . The advice is summarised as follows: ADVICE: following a resubmission iron III isomaltoside 1000 5% (Diafer ® ) is accepted for use within NHS Scotland. Indication under review: For the treatment of iron deficiency in adults with chronickidneydisease (CKD) on dialysis, when oral iron preparations are ineffective or cannot be used. Iron III isomaltoside 1000 at a higher (10%) concentration has been shown to be non-inferior to another intravenous iron product in maintaining haemoglobin concentration
Efficacy and Safety of Sofosbuvir with Simeprevir in Hepatitis C Infected Patients with Severe ChronicKidneyDisease: A Systematic Review and Meta-Analysis Efficacy and Safety of Sofosbuvir with Simeprevir in Hepatitis C Infected Patients with Severe ChronicKidneyDisease: A Systematic Review and Meta-Analysis | BEMS Reports Biology, Engineering, Medicine and Science Reports BEMS Reports - Manuscript Submission / / Efficacy and Safety of Sofosbuvir with Simeprevir in Hepatitis C Infected (...) Patients with Severe ChronicKidneyDisease: A Systematic Review and Meta-Analysis Efficacy and Safety of Sofosbuvir with Simeprevir in Hepatitis C Infected Patients with Severe ChronicKidneyDisease: A Systematic Review and Meta-Analysis Primary tabs Published: August 2016 Type: Original Article Authors: , , , and Author(s) affiliations: Ruchi Singhal 1 , Rajiv Ahlawat 2 , Pramil Tiwari 3 *, Ajay Duseja 4 1 Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research
Lipidomic Signature of Progression of ChronicKidneyDisease in the ChronicRenal Insufficiency Cohort Human studies report conflicting results on the predictive power of serum lipids on progression of chronickidneydisease (CKD). We aimed to systematically identify the lipids that predict progression to end-stage kidney disease.From the ChronicRenal Insufficiency Cohort, 79 patients with CKD stage 2 to 3 who progressed to ESKD over 6 years of follow up were selected and frequency-matched